Tag: health

  • Skechers Takes Control of India Business

    Skechers Takes Control of India Business

    Skechers has bought its joint venture partner in Skechers India, taking the business inhouse. Skechers India has 223 retail locations across the country, 61 of which are company owned and operated, with the remainder franchised. Last year, Skechers saw double-digit increases in wholesale and retail sales and an 80 per cent increase in pairs sold, reaching 2.7 million.

    An additional 80 to 100 stores are planned for this year – of which about 20 will be company-owned.

    The dual-ownership model is expected to allow Skechers India to grow and expand its presence faster, the parent company said in a statement.

    “Skechers is still a relatively young brand in this country, having been in India for less than a decade, yet in the last five years, we have seen significant growth through our joint venture,” said Michael Greenberg, president of Skechers.

    “The substantial existing retail network of over 200 stores, a strong wholesale business and a recently launched e-commerce site is a solid foundation that we can build upon. These accomplishments, as well as opportunities we see to increase the brand’s exposure and drive sales, give us great optimism and confidence for the growth of Skechers in India.”

    Rahul Vira, CEO at Skechers South Asia, said the company was delighted to become a wholly-owned subsidiary of Skechers.

    “This development will enable us to amplify our growth plans, accelerate expansion of our operations and build a stronger network to further gain market share in India,” he said.

    Skechers India will continue operating under its existing structure and from its existing headquarters in Mumbai.

  • Consumer’s Guide To Selecting The Perfect Office Chair

    Consumer’s Guide To Selecting The Perfect Office Chair

    If you work in an office environment be it on a full time or part-time basis, then you must be aware of how much time you spend on that office chair. But ironically, most businesses opt to spend a greater percentage of their furniture expense allocations money on an office desk as opposed to a chair. All this while forgetting the vital role played by quality office chairs on the health, general well-being and productivity at work. Therefore, it’s only fair that you purchase an office chair that’s both supportive and comfortable.

    But before deciding on one, here are a few considerations that should keep in mind;

    Don’t Forget To Examine The Fabric

    What’s important in a piece of fabric if you’re not going to wear it? Well, believe it or not, fabric plays a critical role in determining the quality of an office chair. It’s responsible for maintaining the breath-ability of the chair such that it doesn’t get too hot or cold. This can become extremely uncomfortable especially after long hours of sitting on it. Additionally, still on the fabric, ensure that it comes with a quality cushion to protect the person sitting on it from feeling the hard base of the chair.

    How Adjustable Is it?

    The best description of a perfect office chair revolves around its adjust-ability. Take time to check if the chair can be tilted backward for a more relaxed position, adjusted in height depending on the occupant for better use of the desk and the armrest should be adjustable as well. So when sourcing out for an office chair for sale, ensure to look out for such features. In most cases, these office chairs come with dial-controlled features that allow users to adjust with ease. However, there are still others that allow manual control, which is still okay.

    How Flexible Is The Base?

    While the market is mainly filled wheel-based chairs, you should give special considerations when selecting one. There are specific wheels made specifically for carpets, tiles and even wooden floors. Remember the ability to roll freely gives users the flexibility they require to reach out for stuff around the office. While at it, also ensure that the base can swivel freely to allow you access to various parts of the work desk.

    Does It Have Lumbar Support?

    Remember the back is one of the most important parts of the body when it comes to working in an office setting that requires a lot of sitting. Therefore you have to take care of it. Therefore a quality office chair should offer nothing less but good support for the lower back. If possible go for one with an adjustable lumbar to suit the needs of different users. This helps to prevent back strains that can affect the quality of work.

    To Conclude

    Selecting the correct office that’s not only comfortable but also offers solutions and cushion to back issues is vital for productivity in the workplace. All this can be made possible if you pay close attention to the fabric used, examine its flexibility and ensuring it has an adjustable lumbar support.

     

  • Decathlon opens Singapore megastore

    Decathlon opens Singapore megastore

    French sports chain Decathlon opened its largest store in Singapore late last month, as the European retailer continues to build upon its popularity in the Asian market. Dubbed ‘Decathlon Singapore Lab’, the new experience store is located at Stadium Boulevard and covers 5,000 square metres of retail space, making it the biggest Singapore store. It is also opened 24 hours.

    In addition to Decathlon’s inventory of sports apparel, footwear and accessories, the new ‘Lab’ boasts a series of ‘experiential’ features including an indoor area of four different running surfaces wherein shoppers can test running shoes before purchasing, as well as a hiking path with a gravel surface for the testing products in-store.

    At a media briefing last month, Decathlon Singapore chief executive Yves Claude said the store has been named Decathlon Singapore Lab “because a lab is a disruptive and innovative place where we test new solutions.”

    The store also hosts an Active Health Lab in partnership with Sport Singapore, where users can take a free health assessment and there are free-to-play areas next to the store as well.

    To speed up the delivery process for shoppers, Decathlon has established an in-house conveyor built that transports products as soon as they are ordered online. Shoppers can also order online and collect their items at their preferred store within two hours for free.

    “We have to give new reasons for customers to come back to our store,” added Claude.

    The store is the latest in a string of ‘Decathlon Experience’ stores being rolled out across Singapore and is the fourth in the nation’s offering.

    Decathlon also has a 4,000-square-metre showroom in Joo Koon and two click-and-collect stores.

    In May last year, Decathlon signed a memorandum of understanding with Sport Singapore, which marked the announcement of this new Decathlon in Kallang.

    “We share a common purpose, which is to make sport accessible. They come with a good price point, high-quality products, (and) most importantly, they come with ideas on how to improve participation,” said Lim Teck Yin, Sport Singapore CEO.

  • The shares of Lululemon athletica have risen 90% in 2018

    The shares of Lululemon athletica have risen 90% in 2018

    Over the past 12 months, shares of lululemon athletica have risen 90%. The most recent surge came after an upgrade on 2018 holiday season guidance, helping the athletic-wear stock rebound from a slump brought on by a broad stock market sell-off at the end of the year. Lululemon has enjoyed several tailwinds. Athleisure (that is, activewear and sports-inspired clothing for all situations) has continued to grow in popularity, and consumers have been generously spending — to the tune of 4.9% more on clothing alone in 2018, according to the U.S. Census Bureau. After a blockbuster run, though, Lululemon may have a difficult time repeating that same success in the new year.

    It is easy to see why shares of the clothing company have come roaring back. During the all-important holiday shopping season, management updated revenue guidance to between $1.14 billion and $1.15 billion, up from previous guidance of $1.12 billion. Earnings per share also got an upgrade to a range of $1.72 to $1.74, up from a range of $1.64 to $1.67.

    The results are impressive, but Lululemon has been measured by how it approaches expansion. Through the third quarter of 2018, there were 426 physical stores, up a net 22 from the start of the year. Instead of growing primarily by new openings, the company has instead benefited from a surge in same-store sales at existing stores — which increased 6% during the third quarter — as well as directing traffic to the online store. Direct-to-consumer sales were 25.3% of revenue in the third quarter, compared with 21.2% in the same period in 2017.

    Lululemon is not alone in the athleisure-wear category, though. Gap and its Old Navy and Athleta brands continue to grow their presence in sportswear, and the largest sports-only chain, Dick’s Sporting Goods, has also launched its own branded lines of clothing. Yet in spite of the competition, Lululemon has continued to resonate with new and existing buyers, both here in the states and abroad.

    The maker of stretchy pants and other sports-inspired clothing could nevertheless continue to run higher. After all, Lululemon has momentum on its side, both on the top and bottom lines. Even should sales growth take a breather, management has said it thinks gross profit margin on product sold could continue to expand, especially as a result of the emphasis on direct selling online and new higher-margin products such as coats and sweaters.

    On the other hand, there is reason for investors to give pause before jumping on the bandwagon. Even after earnings nearly doubled in 2018, the stock still trades at a premium, largely because share performance matched that of earnings. The trailing-12-month price-to-earnings (P/E) ratio currently sits at 52.5, a metric that only slightly improves to 43.2 when using free cash flow — a better measure of profitability, as it factors only for basic operating expenses and capital expenditures and excludes items such as depreciation and amortization.

    On a one-year forward basis, the P/E is currently at 40. Paying for decades’ worth of profits that haven’t yet been realized only makes sense if the bottom line continues to expand at breakneck speeds, and that’s what is implied in the rich valuation. Thus, there’s little room for error, and if there’s any slowdown at Lululemon, the stock could suffer losses at current levels.

    Of course, for those looking to the long term, Lululemon looks like a solid bet on the apparel industry of the future. Nevertheless, after renewed investor optimism over new fourth-quarter guidance, the stock is too rich for my taste.

  • Korean firms team up on insurance

    Korean firms team up on insurance

    SK Telecom, Korea’s top mobile carrier, and Hyundai Motor will jointly enter the insurance business, partnering with Hanwha General Insurance to bring their technology expertise to the industry. The Financial Services Commission (FSC), the country’s top financial regulator, said Wednesday it has given preliminary permission for SK Telecom, Hyundai Motor and Hanwha General Insurance to build an online insurance company that primarily deals with miscellaneous non-life insurance on digital platforms.

    “If the process goes smoothly, it can open in the fourth quarter of this year,” said a spokesperson at SK Telecom.

    In six months, the investing units are required to raise the promised capital, complete recruiting and have the physical operation in place, after which it will file for final approval.

    The companies said the unit will focus on cars, pets and travel.

    Hyundai Motor said the insurer will develop a product that differentiates insurance fees depending on a policy holders’ mileage and other driving behavior. Also on the cards is a system that discounts fees when subscribers are found to drive in a safe manner by adopting a real-time analytical technique to monitor driving habits.

    The insurance firm aims to carve out its own niche with lower fees and relatively short contracts.

    “We want to offer attractive alternatives for consumers who found existing insurance products expensive and requiring long-term commitment,” said Jang Yoo-seong, head of the artificial intelligence (AI) and mobility division at SK Telecom.

    The idea is based on InsurTech, a combination of insurance and technology that has quickly risen to prominence in the global financial industry.

    According to a study by the Korea Insurance Research Institute, the market has been rapidly growing in recently years. Investment in InsurTech start-ups, which amounted to $2.6 million in 2013, surged to $11.9 billion in 2017.

    The global InsurTech market revenue is valued at $532.7 million in 2018 and is expected to reach $1,119.8 million by 2023, according to Research and Markets, a U.S. market tracker.

    Hanwha General Insurance will raise 75.1 percent of the capital while SK Telecom puts in 9.9 percent. Hyundai Motor invested 5.1 percent and Altos Ventures Korea, an investment firm, 9.9 percent.

    In total, the companies will funnel in a total of 85 billion won.

    If passed, the new insurer will be the country’s second internet-only insurance company after Kyobo Life Planet.

  • Johnson & Johnson, Apple collaborate for healthcare

    Johnson & Johnson, Apple collaborate for healthcare

    Apple and Johnson & Johnson are teaming up on a study to determine whether the latest Apple Watch, in conjunction with an app from the pharmaceutical company, can accelerate the diagnosis of a leading cause of stroke. Atrial fibrillation, or AFib, is an irregular and often rapid heart rate that causes about 130,000 deaths and 750,000 hospitalizations each year in the U.S., Johnson & Johnson said. Up to 30 percent of cases go undiagnosed until life-threatening complications occur. Worldwide, about 33 million people have the condition.

    The controlled, randomized multi-year Johnson & Johnson study will start later this year and be limited to U.S. adults ages 65 years and older who wear the Apple Watch Series 4. Specific details on how to participate will be released later.

    The Apple Watch Series 4, which costs $399 or more, has an irregular heart rhythm notification feature, as well as an FDA-cleared ECG app, both of which are designed to detect AFib.

    “We are receiving thank you letters daily from Apple Watch wearers who are discovering they have AFib,” said Apple Chief Operating Officer Jeff Williams. “We want a deeper understanding about outcomes and prevention associated with early detection. We are excited to work with Johnson & Johnson, which has a long history and expertise in cardiovascular disease.”

    Paul Stoffels, Johnson & Johnson’s executive vice president and chief scientific officer, said “the goal is to identify early on AFib and prevent stroke by combining the physical know-how from Apple and what we have from the medical and scientific know-how.”

    Cardiologist Paul Burton, Johnson & Johnson’s vice president of medical affairs for internal medicine, added the watch has a good detection rate for the condition, but there can be false positives.

    If an AFib reading appears, patients are directed to seek a formal diagnosis from their medical provider. Johnson & Johnson’s goal is to collect aggregate data from study participants, rather than tracking individual patients.

    “When we do clinical trials, we always respect the privacy of patients,” Stoffels says.

    Burton believes “the study has the potential to show that there is a lot more atrial fibrillation out there in the real world in older people than we ever imagined, and if you use a tool like an Apple Watch to detect and funnel people to care, you can really drive down stroke risk in those patients.”

    Apple CEO Tim Cook recently talked about Apple’s ambitions in the health space. “I think you’ll be able to look back at some point in the future and Apple’s greatest contribution will have been to people’s health. I think it’s that big.”

    In November 2017, Apple teamed up with the Stanford University School of Medicine on an Apple Heart Study app that uses the heart rate sensor inside the Apple Watch to collect data on irregular heart rhythms. That study is ongoing.

    Apple also hopes iPhone owners will store medical records inside the Health app.

    Stoffels says wearable technology will continue to take on increased importance in the health field, from monitoring whether patients take medications to measuring sleep. “Digital and data will become part of everything we do.”

  • Brands planning to cash in on rising menswear trend

    Brands planning to cash in on rising menswear trend

    This week, Nike launched its new collection of yoga wear for men. While this was the company’s first foray into men’s yoga apparel, the move was very much in line with competitors who have been making a push into the menswear apparel market recently. Lululemon, whose bread and butter has long been women’s yoga trousers, is one of those competitors. Former CEO Laurent Potdevin described menswear as one of the brand’s “best-kept secrets.” The company is now looking to grow this division into a billion-dollar business.

    Gap also jumped on the bandwagon last year, with its new casual menswear brand Hill City. But a push into menswear stretches beyond the athletic wear market – Madewell rolled out menswear in September, Saks Fifth Avenue recently closed its womenswear store in Brookfield Place but kept its menswear location open, sisters Mary-Kate and Ashley Olsen launched their own menswear collection for fashion brand The Row last year, and the list continues.

    These brands are all looking to capitalise on a big change in fashion, and that is that in the not too distant future, menswear may outgrow womenswear.

    Business intelligence firm Gartner L2 estimated that in just two years, revenue growth of men’s clothing will surpass that of women’s clothing. This data is backed up by Euromonitor International, which estimated that men’s lines will outperform women’s over the next six years. 

    “Fashion has always been about women but men are finally having their time,” says Lizzy Bowring, catwalk director at trend-forecasting agency WSGN.

    Bowring believes that the rise of a young, fashion-conscious male consumer is a key reason for this. “It’s the younger men that are driving the push for menswear,” she says. “These men are more savvy and aware, and there is a lot of competition to look the part.”

    Ayako Homma, beauty and fashion consultant at Euromonitor International, echoed these thoughts in an email.

    “One key trend is men’s changing perception of fashion. Men are spending more time, effort and money on their grooming and appearance,” she wrote.

    Experts say that this peak in menswear can be traced back to a boom in streetwear clothing, which has been driven by brands such as Supreme, Yeezy, and Off-White. These brands have experienced explosive growth in recent years and are considered to be redefining the fashion landscape.

    These labels have been embraced by luxury players, a move that has in turn given new life to some of the luxury brands.

    Louis Vuitton recently hired industry pro Virgil Abloh to become its new artistic director. Abloh is responsible for setting up perhaps the buzziest streetwear brand of all, Off-White, which was recently ranked the hottest label in the world.

    “The men’s business has exploded in the past five years,” Roopal Patel, fashion director of Saks Fifth Avenue said. Patel said the focus had shifted to bringing in newer menswear-focused labels such as Off-White.

    “We’ve gone from just category addressing to designers looking at how they’re going to wardrobe a man’s lifestyle, everything from work to evening to weekend to sport,” she said.

    Industry insiders say this trend is here to stay. “It’s more than a buzz. It’s a deeper trend,” said Sidney Toledano, head of LVMH’s fashion group. He continued: “There’s strong demand across the men’s fashion industry, in all its shapes and forms, and which comes in part from a younger clientele. We see it very clearly in the sales.”

  • BMW Korea fined $13M over emissions

    BMW Korea fined $13M over emissions

    A Seoul court fined BMW Korea 14.5 billion won ($12.9 million) for manipulating documents on emissions to sell some 29,000 vehicles in Korea. The Seoul Central District Court announced Thursday that the local unit of BMW is guilty of violating customs law. The automaker was found guilty of forging emissions test papers from 2011 to obtain certification from the National Institute of Environmental Research under the Environment Ministry that its cars meet local emissions standards. Roughly 29,000 cars were certified this way, according to the court.

    “The automaker has undermined government efforts to improve air quality in Korea,” the court said in a statement. “This also damaged local customers’ trust in BMW.”

    The court also added that BMW Korea took substantial profits over the years due to the manipulation, showing no effort to abide by local laws.

    “The reason for making [carmakers go through] a stringent certification process is because car emissions have substantial impact on air quality,” the court said.

    The Seoul court also found six former and current executives of the automaker involved in the case guilty. Three executives were sentenced to eight to 10 months in jail, with three others given a four to six month suspended sentence with probation.

    On Thursday’s ruling, BMW Korea said in its official statement that the company “will respond following an appropriate legal process after thoroughly reviewing the case,” adding that it cannot give a “detailed answer yet.”

    Last month, the Korean unit of rival German automaker Mercedes-Benz was also found guilty of violating the emissions certification process. The court gave Mercedes a 2.81 billion won fine and handed down an eight-month jail sentence to the executive in charge of emissions certifications. The carmaker was charged for failing to get new certifications after changing some emissions-related parts. Mercedes said it will appeal the ruling.

    In its official statement last month, Mercedes said it was an administrative mistake, adding that it was unintentional.

  • American fund acquires stake in Vietnamese organic food firm

    American fund acquires stake in Vietnamese organic food firm

    The Seaf Women’s Opportunity Fund has acquired a 30 percent stake in Organica, promising the Vietnam all-round support. While not mentioning the specific investment value, Jennifer Buckley, SEAF’s senior managing director, said the fund will support Organica in operations, distribution, and network expansion. In addition to being a strategic shareholder, the fund will also give Organica a 5-year loan so that it has sufficient resources to finance expansion plans in the future.

    “This is the first organic food company in Vietnam we have decided to invest in, even though the market [for organic products] is still small,” said Jennifer Buckley. She added that if the company performed well, the fund may acquire it in full in the future.

    Pham Phuong Thao, CEO of Organica, said that the current investment will be enough for the company to implement a 2-3 year plan. In particular, it plans to open more retail stores, improve online sales systems, IT systems and human resources, Thao said.

    Organica is an organic groceries chain established in 2013 with the first store in Ho Chi Minh City. It now has 5 stores in Ho Chi Minh City, Hanoi and Da Nang. Currently, the company has 10 farms in the South and the Central Highlands, totalling a combined area of 300 ha.

    SEAF (Small Enterprise Assistance Funds) is an international investment management group that provides growth capital and business assistance to small and medium enterprises (SMEs) in emerging and transition markets.

    It currently operates in 30 countries and has investments in over 300 small businesses.

  • Temasek plans to sell AS Watson stake

    Temasek plans to sell AS Watson stake

    Singapore’s Temasek Holdings is reportedly looking to quit its stake in Hong Kong-headquartered beauty products retailer AS Watson. Temasek spent US$5.6 billion to acquire a 25 per cent share of AS Watson in 2014 from Hong Kong’s CK Hutchison, which retains the majority stake. According to report, Temasek made the investment expecting the business to be listed within three years. But softening investor sentiment towards retail sector listings has weakened since that plan was first envisaged. Investors are spooked by the demise of a slew of brick-and-mortar-focused brands across developed markets.

    AS Watson has some 14,500 stores in 24 markets around the world, and has market leadership in 15 of those. That could make the business an attractive target for private equity funds, despite the company appearing to be focused more on opening new stores than migrating online, where consumers are buying more beauty and healthcare products.

    Bloomberg says in an analysis published online, that a private equity business would be among the more likely buyers for the Temasek stake, given the amount of industry money that’s sitting idle.

    “That said, any acquirer will still be in a minority position, even if the entire 25 per cent is sold. Along with the business’s poor growth prospects, the absence of control is likely to be reflected in the valuation. This is one retail sale that will need a discount to be attractive.”

  • Hyundai Korea recalls diesel vehicles for emissions issue

    Hyundai Korea recalls diesel vehicles for emissions issue

    Hyundai Motor will recall about 79,000 diesel-powered vehicles to fix faulty emission-related components, the Environment Ministry said Tuesday.Korea’s biggest carmaker by sales is expected to recall 78,721 vehicles encompassing three different models due to problematic parts that emit excessive nitrogen oxide into the air. The recall will start Wednesday and be carried out for one and a half years, an official at the Ministry of Environment said.

    The three models are the 2.2-liter diesel-powered Grandeur sedan, the Megatruck and the Mighty truck.

    “The ministry recommended Hyundai to recall 30,945 units of the Grandeur diesel sedan due to a faulty emission part,” the official said over the phone.

    “As for the two truck models, however, the carmaker has voluntarily submitted its recall plan to the ministry, with an approval due to be made this week.”

    Hyundai’s recall plan is in line with the government’s push to reduce diesel-powered vehicles on roads and fine dust, which is harmful to your health.

  • KKR invests into lifestyle products

    KKR invests into lifestyle products

    Private Equity firm KKR has taken up a “significant stake” in massage chair and lifestyle products group V3, the owner of the OSIM and TWG Tea brands. KKR’s investment is up to S$500 million in V3, valuing V3 at an enterprise value of about S$1.7 billion. However,  Both parties declined to comment on the exact mix of equity and debt financing. KKR is making the investment from its Asian Fund III. What we know is that the investment by KKR represents more than 50 percent increase in enterprise value compared to when the group was taken private.

    Ron Sim remains the Chairman, Chief Executive and Controlling Shareholder of V3. He said: “I am extremely pleased to welcome KKR as a significant shareholder in V3. I am confident this investment will position the company for our next phase of growth, starting with the immediate expansion of TWG Tea in Japan and the US and of OSIM in China. We would also be looking into M&A opportunities that are earnings accretive.”

    KKR partner Jaka Prasetya said the investment underscores KKR’s strong belief in the continued growth of the region’s consumer sector: “We aim to provide support and capital to successful home-grown, regional companies like V3 in order to capture opportunities across Asia and beyond.”

    Headquartered in Singapore, V3 has a presence in over 100 cities in 26 countries around the world. The largest chunk of V3’s revenue comes from sales of OSIM massage chairs.

    V3’s annual revenue climbed back above the S$600 million mark last year, reversing the revenue decline owing to store closures in China in prior years. Profit also rose, Mr Sim said.

    The luxury lifestyle and wellness industry continues to be a sector of exciting growth in Asia, proliferated by rapidly rising consumer affluence throughout the region.

  • Amway forays into the herbal oral care segment

    Amway forays into the herbal oral care segment

    Amway India, the country’s largest FMCG direct selling company has announced the launch of its latest innovation – ‘Glister Herbals Toothpaste’, to mark its entry into the herbal oral care market. Building on the success of its globally popular Rs 100 crore brand – Glister, the new herbal oral care product is a seamless blend of numerous herbal ingredients with appealing taste and pleasing color to suit everyone’s palate. With this new and advanced product, Amway aims to target the flourishing Rs 1,980 crores oral care segment in India.

    Announcing the launch of Glister Herbals, Sundip Shah, Chief Marketing Officer, Amway India, said, “Glister has been one of our most popular global brands. A bestseller for over five decades, it has won the trust of millions of consumers worldwide and has been an integral part of their oral hygiene routine. Keeping with our commitment of offering highest quality products and addressing the increasing demand for natural and herbal alternatives for long-term healthy living, Glister Herbals is an expansion of our flagship brand and indigenously developed for our Indian consumers.”

    He further added, “The industry for herbal oral care products has grown significantly in recent years, fueled by consumers’ preference for herbal solutions and trust in their long-term benefits. However, our research empirically highlights the need for likeable sensorials – a gap that exists in the available offerings in the market currently. This often leads to consumers shifting to regular and non-herbal products. Glister Herbals’ has the goodness of herbs with great taste and appealing colour. With this powerful mix, we aim to transform the product usage experience and long-term adoption of herbal toothpastes in the market and I am confident in our latest innovation and its potential to transform the category”

    Anisha Sharma, Category Head, Beauty & Personal Care, Amway India, added, “Glister Herbals is best defined as the herbal oral care solution from Amway offering great taste with the goodness of herbs. This multi-action toothpaste is enriched with 11 ingredients such as spearmint, clove, ginger, neem, mulethi, among others, which are known for their benefits and great taste. It also has biodegradable microbeads of essential oils comprising clove and tea tree to ensure maximum efficacy of the constituents. The goodness of herbs promises 12-hour germ protection and fresh breath benefits along with remineralization and teeth whitening.”

    She further added, “We are excited with the business opportunity offered by the market. In order to ensure national wide reach and to engage consumers, we are introducing digital activations across platforms and organizing dental camps in key markets. As ingredient story and taste is key to the success of our new herbal offering, we have begun taste challenges for our direct sellers for which we have received an overwhelming response. We are sure that the Glister Herbals will receive favorable response from the consumers.”

    Glister Herbals follows the thriving success of Amway’s Nutrilite Traditional Herbs in its Nutrition and Attitude Be Bright Herbals in beauty categories last year.

    Amway Glister Herbals is sold exclusively by Amway Direct Sellers across India and can be easily ordered on the company’s website.

  • Smart Garments: The next big thing in sportswear

    Smart Garments: The next big thing in sportswear

    Fitness wearables are no longer just a matter of wrist straps or pieces of practical jewelry. Such technology now works via our clothing. Smart garments are all set to supercharge the fashion industry in the years to come. We are fortunate to have been living in an era which will go down in history as the apogee of technological advancement.
    Technology is an indispensable part of our life today. It has thoroughly morphed all aspects of human life — right from the way we communicate,travel, exchange information to the way we eat, live and drink. Hence, it is but only natural that technology has heralded a propitious change in the way we dress and clothe ourselves today.

    After the huge success of fitness wearables like Apple Watch, Fitbit, Polar fitness monitors, etc., etc., smartness and intelligence is progressively making inroads into the clothes we wear. The fashion world, more so in the last few years, is abuzz with words like wearable technology, smart garments, intelligent garments, e-textiles, etc.

    Although used interchangeably, in a broad sense, they all refer to any piece of clothing with integrated sensors and digital components. The integrated technology monitors the physical conditions of the user and uses big data analytics to predict and show the results.Newer smart clothing technologies can also sense and monitor the environment condition as well.

    GROWTH DRIVERS

    A recent survey by the World Economic Forum (WEF) reveals that 92.1 percent of corporate leaders believe 10 percent of people will wear clothes connected to the internet by 2025, and 85.5percent believe 105 percent of eyewear will be internet connected.

    Growing use across various industrial verticals such as sports and fitness, healthcare, military and defense is driving the smart clothing market globally. The rising demand for monitoring body activities through sensors is expected to surge the demand for smart clothing market over the forecast timespan. Growing awareness among individuals regarding fitness is providing an impetus to the industry growth. In addition, the inclination of athletes towards the use of these products to prevent injuries and optimize their performance will have a positive impact on the business. Additionally, incorporation of newly developed and advanced fibers such as nanofibers and hybrid materials is expected to drive the growth of smart clothing market.

    THE MARKET SIZE

    As per the US based global market research and management consulting company Global Market Insights Inc., the size of the smart clothing market was over US$ 150 million with shipments of around 800,000 units in 2016. The market is expected to balloon to over US$ 4 billion by 2024, and shipments are forecast to grow at over 50 percent CAGR.

    Smart t-shirts are emerging as one of the most popular and widely used categories of this segment in recent times. Projected to grow at over 50 percent CAGR from 2017 to 2024, these smart garments can provide biometric data such as heart rate, breathing rate and volume, muscle activity, etc., which are utilsed to optimize performance and workout plans professionally. Smart jackets are set to witness growth over the future owing to the ability of these products to control the mobile devices of the wearer and connect to several services such as music and camera, device charging, etc., directly from the jacket.

    Military and defense applications are predicted to witness high growth with a CAGR of over 55 percent from 2017 to 2024. In order to gain visibility into the health of a soldier as well as crucial battlefield insights, various government institutions are investing heavily to develop technologically advanced military uniforms.

    The US smart clothing market, the biggest hitherto in the world, is estimated to witness huge adoption and will dominate the industry with the significant revenue share. Increasing investments by various sports associations to eliminate the possibility of any preventable injuries of highly paid professional athletes is expected to fuel the industry growth.

    The Asia Pacific smart clothing market is expected to witness substantial growth over the forecast timespan. This can be attributed to the growing adoption of various wearable devices coupled with the increasing demand for advanced features in the products. In addition, rising security concerns and increasing military and defense budgets across countries such as India and China is predicted to witness huge demand for these products.

    THE INDIAN SCENARIO

    The smart garments segment is still in its nascent stages in India, and very under-developed compared to its peers in the Asia Pacific.

    The Indian ecosystem is just experiencing the advent of wearable technology and while the initial focus is mainly on the fitness and healthcare sector, there is a lot of scope for innovation in the existing product line – such as gamification, introducing social incentives to encourage community / group adoption as well as building an augmented product by providing a comprehensive set of services and charging based on usage. There are immense opportunities in the other sectors as well.

    Here is a look at some of the best Indian companies who are shelling who are breaking new ground in the smart garment industry:

    SYGNAL – Hyderabad based startup, Broadcast Wearables Pvt Ltd. is an AI based wearables company on a mission to make everyday devices smart. It is the parent holding of SYGNALS who has the distinction of producing the world’s first touch- enabled t-shirt.

    Loaded with a bunch of sensors packed in a small chip, the brand’s smart t-shirts are equipped to track a plethora of things including, the number of steps taken in the entire day, calories burnt even in the slightest form of exercise, floors climbed, distance walked or run. It can also navigate the wearer to a desired location. All the data is synched through Bluetooth to the app, and can be viewed for at least three days.

    LECHAL – Hyderabad based Ducere Technologies Pvt Ltd., is another noteworthy name in the field of Indian smart fashion. The company’s offering Lechal uses GPS to track down the users location through a GPS linked app, which then sends vibrations to his soles, thus telling him which turn to take. Built into the shape of a small pod which comes fitted into insoles, it functions through an app installed on a smartphone. The app also allows the user to keep a record of his route and tracks the steps taken, the distance travelled and the calories burned. The pods have a claimed life of 15 days on each charge.

    BOLTT – Boltt is a ‘sports tech-brand’ that is developing next generation consumer-centric solutions for personal health & fitness. Known for its advanced artificial intelligence (AI) ecosystem, Boltt provides ‘connected fitness solutions’ bundled with the hardware.The hardware includes smart shoes, stride sensor and activity tracker. The Boltt sensor is powered by Garmin’s patented SDM Technology. Boltt’s AI is aimed at solving problems in health and fitness coaching by providing real-time audio feedback and provides customised workout suggestions. As of now, there are Boltt’s wearables portfolio encompasses such as Boltt Fit, Boltt Beat, Boltt Beat 2.0, Boltt Ace, Boltt Verve Luxe, etc.

    ARROW – Popular shirt brand Arrow from Arvind Ltd., launched its first smart shirt and India’s first smart garment in 2016. The Smart Shirt comes with an inbuilt chip on the cuff that can be programmed by downloading the Arrow mobile app on a near field communication (NFC)-enabled smartphone. The Smart Shirt allows the wearer to share things like his LinkenIn profile, his Facebook profile or visiting card through a tap on the shirt’s cuff with a smartphone. Among other functions it performs are connecting via Bluetooth to play your favourite songs on the phone or switching your phone to ‘meeting mode’.

  • Korean drug companies anticipate a strong 2019

    Korean drug companies anticipate a strong 2019

    Korean pharmaceutical companies are entering 2019 with high expectations as several domestic drugs are expected to gain approval from overseas regulators this year. Though the Samsung BioLogics accounting fraud scandal made 2018 a less-than-stellar year for the pharmaceutical industry, bio firms are ready to get back on their feet with new drugs and licenses.

    Daewoong Pharmaceutical is one firm hoping to get the green light for sales of a product in the United States and Europe this year. Nabota, a botulinum toxin, or botox product, was submitted for approval to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency in 2017.

    Last August, Nabota became the first domestic botox product to gain sales approval in Canada after Daewoong acquired the necessary permit from the country’s health authorities.

    Green Cross is another company awaiting FDA approval. Its I.V.-Globulin SN, an immunoglobulin product that treats immune deficiencies, is being reviewed by the agency.

    Though the FDA postponed approval of the drug last September when it requested supplementary documents from the company, Green Cross is optimistic that it will eventually get the go-ahead since I.V.-Globulin SN is already being sold in both Korea and overseas markets, such as Brazil.

    SK Biopharmaceuticals is waiting for the FDA to approve Cenobamate, an antiepileptic drug. Cenobamate is the first drug for which a Korean company has applied for FDA approval independently without going through global partner companies.

    If the drug is approved, SK expects that Cenobamate will become a huge cash cow that can generate up to 1 trillion won ($898.8 million) in annual sales just in the United States. The United States is the world’s largest market for epilepsy drugs.

    Last Thursday, Hanmi Pharmaceutical filed a license application for Rolontis, a drug intended to treat chemotherapy-induced neutropenia, with the FDA through Spectrum Pharmaceuticals. Hanmi is hoping to gain approval by the first half of 2020.

    Korean drug makers are hoping to make progress with clinical trials and technology exports this year.

    Yuhan is currently working with Janssen Biotech to conduct clinical trials for lung cancer drug Lazertinib. Two months ago, Janssen purchased out-licensing rights from Yuhan for Lazertinib in a deal valued at $1.25 billion.

    One of Chong Kun Dang Pharmaceutical’s most highly anticipated drug candidates is the CKD-702 bispecific antibody, an artificial protein used for cancer immunotherapy. Given the growing interest in bispecific antibodies around the world, industry experts predict Chong Kun Dang will be able to export the drug technology as early on as the pre-clinical stage.

    Hanmi and Jeil Pharmaceutical are also expected to complete Phase 2 clinical trials for their obesity drug HM15211 and stroke treatment JPI-289 this year, while SillaJen is due to complete Phase 3 clinical trials for its cancer treatment Pexa-Vec in the coming months.

    “Domestic pharmaceutical firms have tried to venture into the United States, the world’s biggest drug market, and their efforts will lead to real results next year,” said one spokesman from a pharmaceutical firm.